| ■ 영문 제목 : Global Bacterial Disease Diagnostics Market 2023-2027
|
 | ■ 상품코드 : IRTNTR72443-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 2월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아 태평양, 기타 지역
■ 산업 분야 : 의료
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,375,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,400,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
Technavio사는 세계의 세균성 질환 진단 시장 규모가 2022년에서 2027년 사이에 3,766.05백만 달러에 이르며, 예측 기간 동안 연평균 6.28% 감소할 것으로 전망하고 있습니다. 본 조사 보고서는 세계의 세균성 질환 진단 시장에 대해 조사 및 분석을 실시하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, Five Force 분석, 제품별 (소모품, 의료 기기) 분석, 최종 용도별 (병원, 실험실) 분석, 고객 현황, 지역별 현황 (북미, 아시아 태평양, 유럽, 기타 지역, 미국, 캐나다, 독일, 영국, 일본) 분석, 성장 요인/과제/동향, 기업 현황, 기업 분석 등의 내용을 게재하고 있습니다. 또한 본 조사 보고서는 Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd. 와 같은 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・Five Force 분석
・세계의 세균성 질환 진단 시장 규모 : 제품별
- 소모품의 시장 규모
- 의료 기기의 시장 규모
・세계의 세균성 질환 진단 시장 규모 : 최종 용도별
- 병원에서 사용되는 세균성 질환 진단의 시장 규모
- 실험실에서 사용되는 세균성 질환 진단의 시장 규모
・고객 현황
・지역별 현황
- 북미의 세균성 질환 진단 시장 규모
- 유럽의 세균성 질환 진단 시장 규모
- 아시아 태평양의 의 세균성 질환 진단 시장 규모
- 기타 지역의 세균성 질환 진단 시장 규모
- 미국의 세균성 질환 진단 시장 규모
- 캐나다의 세균성 질환 진단 시장 규모
- 독일의 세균성 질환 진단 시장 규모
- 영국의 세균성 질환 진단 시장 규모
- 일본의 세균성 질환 진단 시장 규모
・성장 요인/과제/동향
・기업 현황
・기업 분석
Technavio 사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 세균성 질환 진단 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 Technavio 사의 시장 조사 보고서는 정확한 세균성 질환 진단 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다. |
■ 보고서 개요Global Bacterial Disease Diagnostics Market 2023-2027Technavio has been monitoring the bacterial disease diagnostics market and is forecast to grow by $3766.05 mn during 2022-2027, decelerating at a CAGR of 6.28% during the forecast period. Our report on the bacterial disease diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by integration of digital health in rapid diagnostics for bacterial disease, high prevalence of infectious diseases, and growing number of merger and acquisition (M&A) activities.
Technavio’s bacterial disease diagnostics market is segmented as below:
By Product
• Consumables
• Instruments
By End-user
• Hospitals
• Labs
By Geography
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the growing demand for portable analytical instruments as one of the prime reasons driving the bacterial disease diagnostics market growth during the next few years. Also, increasing number of partnerships and collaborations and clinical developments will lead to sizable demand in the market.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the bacterial disease diagnostics market covers the following areas:
• Bacterial disease diagnostics market sizing
• Bacterial disease diagnostics market forecast
• Bacterial disease diagnostics market industry analysis
Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bacterial disease diagnostics market vendors that include Abbott Laboratories, Accelerate Diagnostics Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Bruker Corp., Danaher Corp., DiaSorin SpA, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., GENERI BIOTECH s.r.o., Great Basin Scientific, Hologic Inc., Meridian Bioscience Inc., Perkin Elmer Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens AG, T2 Biosystems Inc., and Takara Bio Inc. Also, the bacterial disease diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market by Geography
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global bacterial disease diagnostics market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global bacterial disease diagnostics market 2017 – 2021 ($ million)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Consumables – Market size and forecast 2022-2027
o Exhibit 34: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Consumables – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
o 6.4 Instruments – Market size and forecast 2022-2027
o Exhibit 38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 43: Chart on End-user – Market share 2022-2027 (%)
o Exhibit 44: Data Table on End-user – Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 45: Chart on Comparison by End-user
o Exhibit 46: Data Table on Comparison by End-user
o 7.3 Hospitals – Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 7.4 Labs – Market size and forecast 2022-2027
o Exhibit 51: Chart on Labs – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Labs – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Labs – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Labs – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 55: Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share by geography 2022-2027 (%)
o Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 81: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity by geography
o Exhibit 97: Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 104: Abbott Laboratories – Overview
o Exhibit 105: Abbott Laboratories – Business segments
o Exhibit 106: Abbott Laboratories – Key news
o Exhibit 107: Abbott Laboratories – Key offerings
o Exhibit 108: Abbott Laboratories – Segment focus
o 12.4 Accelerate Diagnostics Inc.
o Exhibit 109: Accelerate Diagnostics Inc. – Overview
o Exhibit 110: Accelerate Diagnostics Inc. – Product / Service
o Exhibit 111: Accelerate Diagnostics Inc. – Key offerings
o 12.5 Becton Dickinson and Co.
o Exhibit 112: Becton Dickinson and Co. – Overview
o Exhibit 113: Becton Dickinson and Co. – Business segments
o Exhibit 114: Becton Dickinson and Co. – Key news
o Exhibit 115: Becton Dickinson and Co. – Key offerings
o Exhibit 116: Becton Dickinson and Co. – Segment focus
o 12.6 Bio Rad Laboratories Inc.
o Exhibit 117: Bio Rad Laboratories Inc. – Overview
o Exhibit 118: Bio Rad Laboratories Inc. – Business segments
o Exhibit 119: Bio Rad Laboratories Inc. – Key news
o Exhibit 120: Bio Rad Laboratories Inc. – Key offerings
o Exhibit 121: Bio Rad Laboratories Inc. – Segment focus
o 12.7 bioMerieux SA
o Exhibit 122: bioMerieux SA – Overview
o Exhibit 123: bioMerieux SA – Product / Service
o Exhibit 124: bioMerieux SA – Key offerings
o 12.8 Danaher Corp.
o Exhibit 125: Danaher Corp. – Overview
o Exhibit 126: Danaher Corp. – Business segments
o Exhibit 127: Danaher Corp. – Key news
o Exhibit 128: Danaher Corp. – Key offerings
o Exhibit 129: Danaher Corp. – Segment focus
o 12.9 DiaSorin SpA
o Exhibit 130: DiaSorin SpA – Overview
o Exhibit 131: DiaSorin SpA – Business segments
o Exhibit 132: DiaSorin SpA – Key news
o Exhibit 133: DiaSorin SpA – Key offerings
o Exhibit 134: DiaSorin SpA – Segment focus
o 12.10 EKF Diagnostics Holdings Plc
o Exhibit 135: EKF Diagnostics Holdings Plc – Overview
o Exhibit 136: EKF Diagnostics Holdings Plc – Business segments
o Exhibit 137: EKF Diagnostics Holdings Plc – Key offerings
o Exhibit 138: EKF Diagnostics Holdings Plc – Segment focus
o 12.11 F. Hoffmann La Roche Ltd.
o Exhibit 139: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 140: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 141: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 142: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 143: F. Hoffmann La Roche Ltd. – Segment focus
o 12.12 Hologic Inc.
o Exhibit 144: Hologic Inc. – Overview
o Exhibit 145: Hologic Inc. – Business segments
o Exhibit 146: Hologic Inc. – Key news
o Exhibit 147: Hologic Inc. – Key offerings
o Exhibit 148: Hologic Inc. – Segment focus
o 12.13 Perkin Elmer Inc.
o Exhibit 149: Perkin Elmer Inc. – Overview
o Exhibit 150: Perkin Elmer Inc. – Business segments
o Exhibit 151: Perkin Elmer Inc. – Key news
o Exhibit 152: Perkin Elmer Inc. – Key offerings
o Exhibit 153: Perkin Elmer Inc. – Segment focus
o 12.14 QIAGEN NV
o Exhibit 154: QIAGEN NV – Overview
o Exhibit 155: QIAGEN NV – Product / Service
o Exhibit 156: QIAGEN NV – Key news
o Exhibit 157: QIAGEN NV – Key offerings
o 12.15 Quest Diagnostics Inc.
o Exhibit 158: Quest Diagnostics Inc. – Overview
o Exhibit 159: Quest Diagnostics Inc. – Business segments
o Exhibit 160: Quest Diagnostics Inc. – Key offerings
o Exhibit 161: Quest Diagnostics Inc. – Segment focus
o 12.16 Siemens AG
o Exhibit 162: Siemens AG – Overview
o Exhibit 163: Siemens AG – Business segments
o Exhibit 164: Siemens AG – Key news
o Exhibit 165: Siemens AG – Key offerings
o Exhibit 166: Siemens AG – Segment focus
o 12.17 Takara Bio Inc.
o Exhibit 167: Takara Bio Inc. – Overview
o Exhibit 168: Takara Bio Inc. – Business segments
o Exhibit 169: Takara Bio Inc. – Key offerings
o Exhibit 170: Takara Bio Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market by Geography
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by End-user
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global bacterial disease diagnostics market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – End-user Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Consumables – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Consumables – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Instruments – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Instruments – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Instruments – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Instruments – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ million)
Exhibits43: Chart on End-user – Market share 2022-2027 (%)
Exhibits44: Data Table on End-user – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by End-user
Exhibits46: Data Table on Comparison by End-user
Exhibits47: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Labs – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Labs – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Labs – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Labs – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by End-user ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share by geography 2022-2027 (%)
Exhibits58: Data Table on Market share by geography 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity by geography ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Abbott Laboratories – Overview
Exhibits105: Abbott Laboratories – Business segments
Exhibits106: Abbott Laboratories – Key news
Exhibits107: Abbott Laboratories – Key offerings
Exhibits108: Abbott Laboratories – Segment focus
Exhibits109: Accelerate Diagnostics Inc. – Overview
Exhibits110: Accelerate Diagnostics Inc. – Product / Service
Exhibits111: Accelerate Diagnostics Inc. – Key offerings
Exhibits112: Becton Dickinson and Co. – Overview
Exhibits113: Becton Dickinson and Co. – Business segments
Exhibits114: Becton Dickinson and Co. – Key news
Exhibits115: Becton Dickinson and Co. – Key offerings
Exhibits116: Becton Dickinson and Co. – Segment focus
Exhibits117: Bio Rad Laboratories Inc. – Overview
Exhibits118: Bio Rad Laboratories Inc. – Business segments
Exhibits119: Bio Rad Laboratories Inc. – Key news
Exhibits120: Bio Rad Laboratories Inc. – Key offerings
Exhibits121: Bio Rad Laboratories Inc. – Segment focus
Exhibits122: bioMerieux SA – Overview
Exhibits123: bioMerieux SA – Product / Service
Exhibits124: bioMerieux SA – Key offerings
Exhibits125: Danaher Corp. – Overview
Exhibits126: Danaher Corp. – Business segments
Exhibits127: Danaher Corp. – Key news
Exhibits128: Danaher Corp. – Key offerings
Exhibits129: Danaher Corp. – Segment focus
Exhibits130: DiaSorin SpA – Overview
Exhibits131: DiaSorin SpA – Business segments
Exhibits132: DiaSorin SpA – Key news
Exhibits133: DiaSorin SpA – Key offerings
Exhibits134: DiaSorin SpA – Segment focus
Exhibits135: EKF Diagnostics Holdings Plc – Overview
Exhibits136: EKF Diagnostics Holdings Plc – Business segments
Exhibits137: EKF Diagnostics Holdings Plc – Key offerings
Exhibits138: EKF Diagnostics Holdings Plc – Segment focus
Exhibits139: F. Hoffmann La Roche Ltd. – Overview
Exhibits140: F. Hoffmann La Roche Ltd. – Business segments
Exhibits141: F. Hoffmann La Roche Ltd. – Key news
Exhibits142: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits143: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits144: Hologic Inc. – Overview
Exhibits145: Hologic Inc. – Business segments
Exhibits146: Hologic Inc. – Key news
Exhibits147: Hologic Inc. – Key offerings
Exhibits148: Hologic Inc. – Segment focus
Exhibits149: Perkin Elmer Inc. – Overview
Exhibits150: Perkin Elmer Inc. – Business segments
Exhibits151: Perkin Elmer Inc. – Key news
Exhibits152: Perkin Elmer Inc. – Key offerings
Exhibits153: Perkin Elmer Inc. – Segment focus
Exhibits154: QIAGEN NV – Overview
Exhibits155: QIAGEN NV – Product / Service
Exhibits156: QIAGEN NV – Key news
Exhibits157: QIAGEN NV – Key offerings
Exhibits158: Quest Diagnostics Inc. – Overview
Exhibits159: Quest Diagnostics Inc. – Business segments
Exhibits160: Quest Diagnostics Inc. – Key offerings
Exhibits161: Quest Diagnostics Inc. – Segment focus
Exhibits162: Siemens AG – Overview
Exhibits163: Siemens AG – Business segments
Exhibits164: Siemens AG – Key news
Exhibits165: Siemens AG – Key offerings
Exhibits166: Siemens AG – Segment focus
Exhibits167: Takara Bio Inc. – Overview
Exhibits168: Takara Bio Inc. – Business segments
Exhibits169: Takara Bio Inc. – Key offerings
Exhibits170: Takara Bio Inc. – Segment focus
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations
|
| ※본 조사보고서 [세계의 세균성 질환 진단 시장 (2023년~2027년)] (코드 : IRTNTR72443-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 세균성 질환 진단 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!
